Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View

TNFα-targeting therapy with the use of the drugs Etanercept, Infliximab, and Adalimumab is used in the clinical treatment of various inflammatory and immune diseases. Although all of these reagents function to disrupt the interaction between TNFα and its receptors, clinical investigations showed the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Hu, Shi, Liang, Shuaiyi, Guo, Huaizu, Zhang, Dapeng, Li, Hui, Wang, Xiaoze, Yang, Weili, Qian, Weizhu, Hou, Sheng, Wang, Hao, Guo, Yajun, Lou, Zhiyong
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Biochemistry and Molecular Biology 2013
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3779706/
https://ncbi.nlm.nih.gov/pubmed/23943614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M113.491530
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk